Viscosupplementation Global Market Report 2024 - By Report, Size, Share, Demand, Forecast To 2033

The viscosupplementation market size has grown rapidly in recent years. It will grow from $3.74 billion in 2023 to $4.15 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to aging population, rising obesity rates, enhanced insurance coverage, growing awareness, patient preference, increased osteoarthritis cases.

The viscosupplementation market size is expected to see rapid growth in the next few years. It will grow to $6.19 billion in 2028 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to regulatory support, alternative payment models, increased healthcare expenditure, research and development, expansion of indications.. Major trends in the forecast period include outcome-based payment models, patient education initiatives, biomarker development, gene therapy research, value-based care models.

Market Overview -
Viscosupplementation refers to a process where hyaluronic acid, a fluid that resembles gel, is injected straight into the joint. Synovial fluid around joints naturally contains hyaluronic acid, which helps lessen friction while moving.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=9836&type=smp

Osteoarthritis Surge Fuels Viscosupplementation Market Growth
The rise in the prevalence of osteoarthritis is expected to propel the growth of the viscosupplementation market going forward. Osteoarthritis refers to a degenerative joint disease, also known as a common form of arthritis, in which the joints start to break down, mostly in the hips, knees, and hands. Viscosupplementation treatment helps to reduce pain and facilitate smooth bone movement by injecting hyaluronic acid straight into the bone joints which enables a reduction in pain and improves the bone's functionality. For instance, according to the Centers for Disease Control and Prevention (CDC), a US-based public health service organization, in the USA, 78.4 million adults aged 18 years and older are projected to have arthritis by 2040. Therefore, the rise in the prevalence of osteoarthritis is driving the growth of the viscosupplementation market going forward.

Competitive Landscape -
Major companies operating in the viscosupplementation market report are Seikagaku Corporation, Anika Therapeutics Inc., Bioventus LLC, Sanofi S.A., Zimmer Biomet, Avanos Medical Inc., Johnson & Johnson Services Inc., Aptissen S.A., Smith & Nephew Plc., Teva Pharmaceutical Industries Ltd., Merck KGaA, Flexion Therapeutics Inc., Regen Lab SA, OrthogenRx Inc., Fidia Farmaceutici S.P.A, Ferring Pharmaceuticals, Wellchem Pharmaceuticals Pte Ltd., Chugai Pharmaceutical Corp., Laboratoires VIVACY, LG Life Sciences Ltd., Miravo Healthcare, Neopharmed Gentili S.p.A., SingHealth Group., Viatris, Allergan, Hoffmann-La Roche, Meda Pharmaceuticals, Merz Pharma, Mylan N.V., Novartis International AG.

Technological Strides Transforming The Viscosupplementation Market
Technological advancements are the key trends gaining popularity in the viscosupplementation market. Companies operating in the viscosupplementation market are adopting new technologies to sustain their position in the market. In August 2021, Seikagaku Corporation, a Japanese pharmaceutical company, introduced HyLink®, a novel viscosupplement administered via intra-articular single injection, aimed at addressing knee osteoarthritis. HyLink® is being integrated with cross-linking technology. This cross-linking technology is used to make the cross-linked hyaluronate hydrogel that remains for a long time in the joint cavity and is the main ingredient in HyLink®, which makes it a long-lasting treatment.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/viscosupplementation-global-market-report

Key Segments -
The viscosupplementation market covered in this report is segmented -
1) By Type: Single Injection Viscosupplementation, Three Injection Viscosupplementation, Five Injection Viscosupplementation
2) By Source: Avian Origin, Non-Avian Origin
3) By Hyaluronic Acids: Standard Hyaluronic Acid, Stabilized Hyaluronic Acid
4) By Application: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis
5) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model"

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.